Has Chinenyenwa Anugwom received payments from drug or device companies?

Yes. Drug and device makers reported $2,184 in general payments to Chinenyenwa Anugwom across 91 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chinenyenwa Anugwom did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chinenyenwa Anugwom come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chinenyenwa Anugwom

Family Medicine · San Joaquin, CANPI 1619406063

Payments from drug & device makers

$2,184in general payments, 2019–2025

Across 91 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$429
AstraZeneca$420
Novo Nordisk$241
Pfizer$188
Exact Sciences$147
Boehringer Ingelheim$127
plus $632 from 14 others

What the payments were for

Food & beverage$2,17299%
Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	21	$429
AstraZeneca	11	$420
Novo Nordisk	8	$241
Pfizer	10	$188
Exact Sciences	7	$147
Boehringer Ingelheim	2	$127
Dynavax Technologies Corporation	4	$99
AbbVie	3	$78
GSK	4	$72
Astellas Pharma US Inc	3	$61
Phathom Pharmaceuticals, Inc.	2	$45
Cranial Technologies, Inc	3	$45
Merck	2	$42
Sanofi Pasteur Inc.	2	$39
Shield Therapeutics Inc	2	$33
VBI Vaccine (delaware) Inc.	2	$33
Mayne Pharma Commercial LLC	2	$29
Bayer	1	$20
Biohaven Pharmaceutical Holding Company Ltd.	1	$19
Organon	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,184 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	84	$81,976
MounjaroTirzepatide	61	$64,802
OzempicSemaglutide	29	$29,880
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	21	$8,348
Atorvastatin Calcium	146	$2,311
Levothyroxine Sodium	28	$1,502
Metformin Hcl	116	$847
Omeprazole	40	$696
Lisinopril	82	$537
Losartan Potassium	41	$515
Rosuvastatin Calcium	13	$404
ClopidogrelClopidogrel Bisulfate	22	$392
Albuterol Sulfate HfaAlbuterol Sulfate	13	$382
Amlodipine Besylate	66	$378
Pioglitazone Hcl	28	$342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Boehringer IngelheimJardiance	$127	$81,97684 claims
Lilly USA, LLCMounjaro	$429	$64,80261 claims
Novo NordiskOzempic	$241	$29,88029 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,533 family medicine providers in California.

Other family medicine in San Joaquin

Amina HaggagNorthridge$112.8M
Steven ReynoldsLong Beach$53M
Rizwana MohseniLake Forest$26.7M
Daniel JohnsonSan Diego$15.7M
Stacey LayleSan Diego$14.8M
Apinya VutikullirdCypress$14.3M
Hanid AudishSpring Valley$13.6M
Augusto FocilOxnard$12.6M
Jack VuLong Beach$10.1M
Suzanne FussellOxnard$8.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →